Cardiologists are emphasizing the importance of regular physical activity to prevent blood clots, which are responsible for approximately 274 death...
Bachem, a company specializing in the development and manufacture of peptides and oligonucleotides, has reported significant financial growth in th...
AstraZeneca has announced that its investigational treatment for myasthenia gravis, gefurulimab, has successfully cleared a Phase III trial. The tr...
AstraZeneca announced that its investigational treatment gefurulimab for myasthenia gravis has successfully completed a Phase III trial, meeting al...
Medtronic plc, a prominent player in the healthcare industry, has received CE mark clearance to expand the indications of its MiniMed 780G insulin ...
AstraZeneca has announced a significant investment of $50 billion into its U.S. operations over the next five years. This move aims to expand its m...
AstraZeneca plans to invest $50 billion in the U.S. by 2030 to expand manufacturing and research capabilities amid looming threats of tariffs up to...
The Food and Drug Administration (FDA) is facing scrutiny over proposed drug pricing reforms, specifically the Most Favored Nation (MFN) policies. ...
ABC News' Dr. Tara Narula has examined the role of diet in weight loss, discussing how dietary choices can significantly impact one's ability to lo...
Galderma Group AG has announced its financial results for the first half of 2025, reporting record net sales of 2.448 billion USD, marking a 12.2% ...